3 articles
People with asthma and chronic obstructive pulmonary disease (COPD) who take the GLP-1 receptor agonist semaglutide appear to suffer significantly fewer acute respiratory attacks, according...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...